BIOA
Income statement / Annual
Last year (2023), BioAge Labs, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, BioAge Labs, Inc.'s net income was -$63.85 M.
See BioAge Labs, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
12/31/2013 |
| Operating Revenue |
$0.00 |
$0.00 |
$14.94 M |
$8.27 M |
$2.17 M |
$1.54 M |
$2.67 M |
| Cost of Revenue |
$0.00
|
$0.00
|
$22.32 M
|
$13.67 M
|
$2.61 M
|
$6.04 M
|
$2.69 M
|
| Gross Profit |
$0.00
|
$0.00
|
-$7.38 M
|
-$5.39 M
|
-$440,828.00
|
-$4.50 M
|
-$23,782.00
|
| Gross Profit Ratio |
0
|
0
|
-0.49
|
-0.65
|
-0.2
|
-2.92
|
-0.01
|
| Research and Development Expenses |
$33.89 M
|
$30.52 M
|
$5.47 M
|
$7.20 M
|
$20.29 M
|
$15.16 M
|
$16.58 M
|
| General & Administrative Expenses |
$14.51 M
|
$9.45 M
|
$10.41 M
|
$6.54 M
|
$6.59 M
|
$6.17 M
|
$5.03 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$1.94 M
|
$2.91 M
|
$4.00 M
|
$4.48 M
|
$4.73 M
|
| Selling, General & Administrative Expenses |
$14.51 M
|
$9.45 M
|
$12.35 M
|
$9.46 M
|
$10.59 M
|
$10.66 M
|
$9.76 M
|
| Other Expenses |
$0.00
|
$0.00
|
$84.82 M
|
$7.58 M
|
$7.21 M
|
$4.89 M
|
$14.82 M
|
| Operating Expenses |
$48.40 M
|
$39.97 M
|
$102.63 M
|
$24.24 M
|
$38.09 M
|
$30.70 M
|
$41.16 M
|
| Cost And Expenses |
$48.40 M
|
$39.97 M
|
$124.96 M
|
$37.90 M
|
$40.70 M
|
$36.75 M
|
$43.85 M
|
| Interest Income |
$2.43 M
|
$465,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$7.79 M
|
$241,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$7.43 M
|
| Depreciation & Amortization |
$162,000.00
|
$129,000.00
|
$9.35 M
|
$9.16 M
|
$4.16 M
|
$1.37 M
|
$1.71 M
|
| EBITDA |
-$45.81 M |
-$39.38 M |
-$88.72 M |
-$13.29 M |
-$33.07 M |
-$44.98 M |
-$38.84 M |
| EBITDA Ratio |
0
|
0
|
-5.94
|
-1.61
|
-15.23
|
-29.15
|
-14.57
|
| Operating Income Ratio |
0
|
0
|
-7.36
|
-3.58
|
-17.74
|
-22.82
|
-15.45
|
| Total Other Income/Expenses Net |
-$15.45 M
|
$247,000.00
|
$7.91 M
|
$1.28 M
|
-$2.65 M
|
-$12.02 M
|
$7.49 M
|
| Income Before Tax |
-$63.85 M
|
-$39.72 M
|
-$102.11 M
|
-$28.35 M
|
-$41.17 M
|
-$47.22 M
|
-$33.69 M
|
| Income Before Tax Ratio |
0
|
0
|
-6.83
|
-3.43
|
-18.96
|
-30.6
|
-12.64
|
| Income Tax Expense |
$0.00
|
$241,000.00
|
$81,735.00
|
$25,646.00
|
-$3,786.00
|
$75,371.00
|
$102,794.00
|
| Net Income |
-$63.85 M
|
-$39.72 M
|
-$98.15 M
|
-$22.48 M
|
-$37.23 M
|
-$46.42 M
|
-$33.22 M
|
| Net Income Ratio |
0
|
0
|
-6.57
|
-2.72
|
-17.14
|
-30.08
|
-12.46
|
| EPS |
0 |
0 |
-2.34 |
-0.78 |
-1.52 |
-2.32 |
-2.13 |
| EPS Diluted |
0 |
0 |
-2.34 |
-0.66 |
-1.32 |
-1.65 |
-1.18 |
| Weighted Average Shares Out |
$0.00
|
$0.00
|
$41.95 M
|
$28.67 M
|
$24.50 M
|
$20.02 M
|
$15.59 M
|
| Weighted Average Shares Out Diluted |
$0.00
|
$0.00
|
$41.95 M
|
$34.19 M
|
$28.18 M
|
$28.18 M
|
$28.18 M
|
| Link |
|
|
|
|
|
|
|
